Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Inari Medical Inc
(NQ:
NARI
)
42.88
-0.35 (-0.82%)
Streaming Delayed Price
Updated: 2:39 PM EDT, Sep 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Inari Medical Inc
< Previous
1
2
3
4
Next >
12 Health Care Stocks Moving In Monday's After-Market Session
January 10, 2022
Gainers Inari Medical (NASDAQ:NARI) stock...
Via
Benzinga
The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance
November 10, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus MorphoSys COO To Leave To Pursue Other Opportunities MorphoSys AG (NASDAQ:...
Via
Benzinga
Exposures
COVID-19
Earnings Scheduled For August 10, 2021
August 10, 2021
Companies Reporting Before The Bell • Nautilus Biotechnology (NASDAQ:NAUT) is expected to report earnings for its second quarter. • Fulcrum Therapeutics (NASDAQ:...
Via
Benzinga
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
August 08, 2021
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,...
Via
Benzinga
Exposures
Product Safety
Inari Medical, Inc. (NARI) Q3 2021 Earnings Call Transcript
November 10, 2021
NARI earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Recap: Inari Medical Q3 Earnings
November 09, 2021
Inari Medical (NASDAQ:NARI) reported its Q3 earnings results on Tuesday, November 9, 2021 at 04:01 PM. Here's what investors need to know about the announcement. Earnings...
Via
Benzinga
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
November 09, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For Acceleron Deal In Germany, Austria, Announces...
Via
Benzinga
3 Under-the-Radar COVID Stocks
October 20, 2021
Some COVID-19 stocks are pretty famous. But other lesser-known names are flying high, too.
Via
The Motley Fool
Exposures
COVID-19
President And CEO Of Inari Medical Makes $2.4M Sale
October 08, 2021
William Hoffman, President And CEO at Inari Medical (NASDAQ:NARI), made a large insider sell on October 7, according to a new SEC filing. What Happened: A Form 4 filing from the...
Via
Benzinga
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Inari Medical Earnings Perspective: Return On Invested Capital
September 22, 2021
Pulled from Benzinga Pro data, Inari Medical (NASDAQ:NARI) showed a loss in earnings since Q1, totaling $4.11 million. Sales, on the other hand, increased by 10.55% to $63.45...
Via
Benzinga
Wall Street Thinks This Healthcare Stock Could Double Your Money in the Next Year
August 24, 2021
Even the median estimate would be a 70% gain.
Via
The Motley Fool
This Healthcare Company Just Shocked Its Investors
August 18, 2021
The stock price is collapsing as a result.
Via
The Motley Fool
66 Biggest Movers From Yesterday
August 12, 2021
Gainers Rani Therapeutics Holdings, Inc. (NASDAQ: RANI) shares jumped 50.5% to close at $20.74 on Wednesday. The company, last month, priced its IPO at $11 per share. Dyadic...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
Inari Medical Plunged 15% After Mixed Q2 Earnings, Lifting FY21 Sales Guidance
August 11, 2021
Inari Medical Inc's (NASDAQ: NARI) Q2 revenue was $63.5 million, more than doubled from $25.4 million in Q2 FY20, beating the consensus of $59.6 million. The growth...
Via
Benzinga
Dow, S&P 500 Extend Highs After CPI Reading
August 11, 2021
The Dow and S&P 500 both nabbed intraday record highs today, the Nasdaq slipped lower.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Wednesday's Intraday Session
August 11, 2021
Gainers Dyadic International (NASDAQ:DYAI) stock increased by 28.96% to $4.63 during Wednesday's regular session. Trading volume for this security as of 12:30 EST is...
Via
Benzinga
Why Shares of Inari Medical Are Falling Today
August 11, 2021
Dollars outpaced procedures in the second quarter.
Via
The Motley Fool
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
August 11, 2021
Gainers CohBar (NASDAQ:CWBR) stock moved upwards by 68.21% to $2.17 during Wednesday's pre-market session. The company's market cap stands at $134.0 million. The...
Via
Benzinga
22 Stocks Moving in Wednesday's Pre-Market Session
August 11, 2021
Gainers CohBar, Inc. (NASDAQ: CWBR) shares rose 78.3% to $2.30 in pre-market trading after the company reported results from the Phase 1a/1b study of CB4211 under development for...
Via
Benzinga
Forget Robinhood, These 3 Healthcare Stocks Are Better Buys
August 11, 2021
Wait for pitches that are easy to hit before taking a swing.
Via
The Motley Fool
Inari Medical, Inc. (NARI) Q2 2021 Earnings Call Transcript
August 11, 2021
NARI earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
7 Stocks Moving In Tuesday's After-Hours Session
August 10, 2021
Gainers Upstart (NASDAQ: UPST) shares are trading higher after the company reported better-than-expected Q2 EPS and sales results and issued Q3 sales guidance above estimates. The...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
August 10, 2021
Gainers CohBar (NASDAQ:CWBR) shares incr...
Via
Benzinga
Inari Medical: Q2 Earnings Insights
August 10, 2021
Shares of Inari Medical (NASDAQ:NARI) decreased in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 143.75% year over...
Via
Benzinga
The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts
August 10, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 9) Adagio Therapeutics, Inc. (...
Via
Benzinga
Exposures
COVID-19
3 Things I'm Looking For in Inari Medical's Earnings
August 10, 2021
What does normal look like?
Via
The Motley Fool
3 COVID Stocks That Could Soar Higher
August 03, 2021
Here's why Pfizer, Inari Medical, and Novavax shares might be more valuable in 2021.
Via
The Motley Fool
Topics
Economy
Exposures
COVID-19
Economy
2 Best Buys of the Nasdaq Right Now
July 28, 2021
The overall market might be expensive, but these stocks aren't.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
Investors Face New Risks In Stock Market Forecast For The Next Six Months
June 24, 2021
Stocks are at a crossroads, with new risks taking shape even as the market hits new highs.
Via
Investor's Business Daily
Topics
Economy
Exposures
COVID-19
Economy
Inari Medical: Return On Capital Employed Insights
June 18, 2021
Looking at Q1, Inari Medical (NASDAQ:NARI) earned $7.71 million, a 10.25% increase from the preceding quarter. Inari Medical also posted a total of $57.40 million in sales, a 18....
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.